We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

120 hedge funds and large institutions have $252M invested in Aldeyra Therapeutics in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 37 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 37

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

1% more funds holding

Funds holding: 119 → 120 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.18% less ownership

Funds ownership: 66.64% → 64.46% (-2.2%)

23% less capital invested

Capital invested by funds: $328M → $252M (-$75.2M)

38% less call options, than puts

Call options by funds: $1.34M | Put options by funds: $2.16M

Holders
120
Holders Change
+1
Holders Change %
+0.84%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
41
Reduced
37
Closed
14
Calls
$1.34M
Puts
$2.16M
Net Calls
-$820K
Net Calls Change
+$2.53M

Top Buyers

1
BlackRock
BlackRock
New York
+$1.04M
2
Two Sigma Investments
Two Sigma Investments
New York
+$1.01M
3
Citadel Advisors
Citadel Advisors
Florida
+$999K
4
LCM
Laurion Capital Management
New York
+$946K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$740K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.02M
2
Invesco
Invesco
Georgia
-$3.47M
3
Marshall Wace
Marshall Wace
United Kingdom
-$1.54M
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$1.42M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$1.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.18M -$1.74K -234 -0.1%
Goldman Sachs
27
Goldman Sachs
New York
$1.13M -$213K -28,753 -15%
PAI
28
Palo Alto Investors
California
$1.07M – – –
Barclays
29
Barclays
United Kingdom
$924K +$84.9K +11,447 +9%
WC
30
Woodstock Corp
Massachusetts
$916K – – –
Jane Street
31
Jane Street
New York
$885K +$577K +77,785 +142%
CAM
32
ClariVest Asset Management
California
$869K – – –
Charles Schwab
33
Charles Schwab
California
$839K – – –
Citigroup
34
Citigroup
New York
$755K +$215K +29,031 +35%
Swiss National Bank
35
Swiss National Bank
Switzerland
$681K – – –
Thrivent Financial for Lutherans
36
Thrivent Financial for Lutherans
Minnesota
$658K -$90K -12,124 -11%
UBS Group
37
UBS Group
Switzerland
$498K -$109K -14,634 -16%
HWAM
38
Hennion & Walsh Asset Management
New Jersey
$492K +$258K +34,796 +90%
Simplex Trading
39
Simplex Trading
Illinois
$478K +$532K +71,639 New
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$454K +$60.3K +8,122 +14%
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$451K +$391K +52,725 +355%
Group One Trading
42
Group One Trading
Illinois
$438K +$486K +65,546 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$418K +$22.4K +3,018 +5%
ECM
44
ExodusPoint Capital Management
New York
$405K +$450K +60,649 New
CS
45
Credit Suisse
Switzerland
$362K -$74.7K -10,073 -16%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$345K -$37.2K -5,015 -9%
RJA
47
Raymond James & Associates
Florida
$341K -$5.65K -761 -1%
AllianceBernstein
48
AllianceBernstein
Tennessee
$337K -$1.26M -170,090 -77%
NSIM
49
North Star Investment Management
Illinois
$334K – – –
Invesco
50
Invesco
Georgia
$321K -$3.47M -467,263 -91%
1
2
3 4 5

ALDX Hedge Fund Activity: Q3 2023 in Review

120 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q3 2023, worth a combined $252M — down 23% from $328M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ALDX positions and 14 closed out — a net gain of 1 holder — while 41 added to existing stakes and 37 trimmed.

The largest buyer was BlackRock, adding an estimated $1.04M. The largest seller was Fidelity Investments, cutting an estimated $5.02M.

  • 120 institutional investors held Aldeyra Therapeutics (ALDX) as of Q3 2023, up from 119 in Q2 2023.
  • Funds reported $252M of Aldeyra Therapeutics stock for Q3 2023, down 23% quarter-over-quarter.
  • 15 funds opened new Aldeyra Therapeutics positions in Q3 2023 and 14 closed out, a net change of +1 holder.
  • The largest Aldeyra Therapeutics buyer in Q3 2023 was BlackRock, an estimated $1.04M added.
  • The largest Aldeyra Therapeutics seller in Q3 2023 was Fidelity Investments, an estimated $5.02M sold.

Based on aggregated 13F filings for Q3 2023.